Illumina said last week that it saw “continued strong demand” in the second quarter for its Genome Analyzer II, which now generates up to 15 gigabases of data per run at the company.
 
As part of its second-quarter financial report, the company also said that it will acquire Avantome, a privately held company developing a low-cost, long-read sequencing technology (see related article, this issue).
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.